Showing results (111-120 of 376) with videos related to

Sort By:
Pageof 38
AIDS (London, England)|June 17, 2004
Improvement of dyslipidemia in patients switching from stavudine to tenofovir: preliminary resultsPere Domingo, Pablo Labarga, Rosario Palacios, et al.
HIV Clinical Trials|February 6, 2010
Efficacy and safety of switching from enfuvirtide to raltegravir in patients with virological suppressionJosé R Santos, Josep M Llibre, Elena Ferrer, et al.
Current HIV Research|November 16, 2010
Differential effects of efavirenz and lopinavir/ritonavir on human adipocyte differentiation, gene expression and release of adipokines and pro-inflammatory cytokinesJose M Gallego-Escuredo, M Del Mar Gutierrez, Julieta Diaz-Delfin, et al.
AIDS Research and Human Retroviruses|June 3, 2016
Short Communication: Maraviroc Once-Daily: Experience in Routine Clinical PracticeMaria Saumoy, Josep M Llibre, Alberto Terrón, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 27, 2005
Lack of association of SDF-1 3'A variant allele with long-term nonprogressive HIV-1 infection is extended beyond 16 yearsFrancesc Vidal, Joaquim Peraire, Pere Domingo, et al.
The Journal of Antimicrobial Chemotherapy|November 15, 2007
Long-distance interactive expert advice in highly treatment-experienced HIV-infected patientsJosep M Llibre, Pere Domingo, Miguel A del Pozo, et al.
Antiviral Research|May 25, 2016
Impact of elvitegravir on human adipocytes: Alterations in differentiation, gene expression and release of adipokines and cytokinesRicardo Moure, Pere Domingo, José M Gallego-Escuredo, et al.
Biomed Research International|August 30, 2014
Prevalence of ischemic heart disease and management of coronary risk in daily clinical practice: results from a Mediterranean cohort of HIV-infected patientsPatricia Echeverría, Pere Domingo, Josep-María Llibre, et al.
Pageof 38